4//SEC Filing
RITTER PHARMACEUTICALS INC 4
Accession 0001382963-15-000081
$AIXCCIK 0001460702operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 8:08 PM ET
Size
7.3 KB
Accession
0001382963-15-000081
Insider Transaction Report
Form 4
Ritter Andrew J
DirectorPresident
Transactions
- Conversion
Common Stock
2015-06-29+817,272→ 817,272 total(indirect: By LLC) - Conversion
Convertible Preferred Stock
2015-06-29−817,272→ 0 total(indirect: By LLC)→ Common Stock (817,272 underlying)
Footnotes (2)
- [F1]Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Stonehenge Partners LLC converted into Common Stock of the issuer on a one-for-one basis and had no expiration date.
- [F2]As a managing partner of Stonehenge Partners LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
Documents
Issuer
RITTER PHARMACEUTICALS INC
CIK 0001460702
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001460702
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 8:08 PM ET
- Size
- 7.3 KB